Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: The Rancho Bernardo Study
- Author(s): von Mühlen, Denise G;
- Greendale, Gail A;
- Garland, Cedric F;
- Wan, Lori;
- Barrett-Connor, Elizabeth
- et al.
Vitamin D (25(OH)D) increases the efficiency of intestinal calcium absorption. Low levels of serum calcium stimulate the secretion of parathyroid hormone (PTH), which maintains serum calcium levels at the expense of increased bone turnover, bone loss and increased risk of fractures. We studied the association between 25(OH)D and PTH levels, and their associations with bone mineral density (BMD), bone loss, and prevalence of hip fractures in 615 community-dwelling postmenopausal aged 50 - 97 years. Mean level of 25(OH)D and PTH were 102.0 nmol/l +/- 35.0 nmol/l and 49.4 ng/l +/- 23.2 nmol/l, respectively; 49% of women were current hormone therapy users. The overall prevalence of vitamin D insuficiency (25(OH) 65 ng/l) was 17.4%. In multiple linear regression analyses hip BMD was negatively and independently associated with PTH levels (p = 0.04), and positively and independently associated with 25(OH)D levels (p = 0.03). There were only 23 women (3.7%) who experienced a hip fracture. In age-adjusted analyses there were no signifcant differences of 25(OH)D and PTH levels by hip fracture status. Across the entire range of values, the overall correlation between 25(OH)D and PTH was moderate (r = -0.20). However, after the threshold vitamin D level of 120 nmol/l, all PTH values were below 65 ng/l. Further studies are necessary to identify the optimal vitamin D levels necessary to prevent secondary hyperparathyroidism.